AAV8-AIPL1 gene therapy (Fondazione Telethon)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAAV8-AIPL1 gene therapy (Fondazione Telethon)
Drug Alias NameAIPL1 gene therapy(Fondazione Telethon)Leber's congenital amaurosis gene therapy (Fondazione Telethon)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFondazione Telethon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFondazione Telethon
Active IndicationsN/A
Inactive IndicationsLeber Congenital Amaurosis

Other Information

ATC CodeN/A
Related LinksN/A